Merck & Co. Inc.
[WKN: A0YD8Q | ISIN: US58933Y1055]
Aktienkurse
97,200€ 1,78%
Echtzeit-Aktienkurs Merck & Co. Inc.
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

JEFFERIES stuft MERCK KGAA auf Buy

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Merck KGaA nach der Einstellung zweier Phase-III-Studien mit…

Aqilion regains rights to TAK1 program

AQILION AB (publ) announces that Aqilion and Merck have decided to terminate the joint development of the TAK1 program. Data…

5 Biggest Pharmaceutical ETFs in 2024

The global pharmaceutical market reached a total value of US$1.6 trillion in 2023, according to Statista, up significantly from the…

Merck acquires EyeBio in up to $3B deal

Merck & Co Inc (NYSE:MRK, ETR:6MK) announced it is acquiring Eyebio, a privately held ophthalmology-focused biotech firm, in a deal…